A study assessing Favipiravir for COVID-19 in Turkey
Latest Information Update: 02 Sep 2020
At a glance
- Drugs Favipiravir (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 02 Sep 2020 New trial record
- 26 Aug 2020 According to a Zhejiang Hisun Pharmaceutical Media Release, preliminary results from this study were published in Lancet.
- 26 Aug 2020 Preliminary results published in the Zhejiang Hisun Pharmaceutical Media Release